Target intelligence / Profile preview

DNA Gyrase (Bacterial Type II Topoisomerase) (DNA Gyrase)

Target
DNA Gyrase
Molecular classification
Enzyme, Topoisomerase, Type II Topoisomerase
01

Overview

DNA gyrase is an essential bacterial enzyme classified as a type II topoisomerase. It catalyzes the ATP-dependent introduction of negative supercoils into double-stranded, closed-circular DNA, a function unique among topoisomerases. This activity is critical for managing DNA topology during processes such as replication and transcription in bacteria. The enzyme is a heterotetramer composed of two GyrA and two GyrB subunits. GyrA subunit is responsible for binding and encapsulating DNA; contains the active site tyrosine. GyrB subunit contains ATP-binding and hydrolysis sites. Essential in all bacteria but absent from higher eukaryotes—making it an attractive target for antibacterial drugs such as fluoroquinolones. These drugs inhibit gyrase activity either by stabilizing cleavage complexes or blocking enzymatic function directly. Resistance development has prompted ongoing research into new inhibitors targeting different aspects or conformations within its catalytic cycle.

Other names
Bacterial Type II TopoisomeraseGyraseTopoisomerase II (Bacterial)
02

Mechanism of action

Fluoroquinolones inhibit gyrase activity either by stabilizing cleavage complexes or blocking enzymatic function directly.

03

Biological functions

DNA supercoilingDNA topology managementDNA replicationDNA transcriptionDNA recombination
04

Disease associations

InfectionBacterial infection
05

Safety considerations

Resistance development to fluoroquinolonesOff-target effects of fluoroquinolones
06

Interacting drugs

Fluoroquinolones

Beyond the preview

Go deeper on DNA Gyrase (Bacterial Type II Topoisomerase) (DNA Gyrase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA Gyrase (Bacterial Type II Topoisomerase) (DNA Gyrase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call